{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:25:31Z","timestamp":1765758331341},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/mbc.0b013e32835e5337","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T14:33:01Z","timestamp":1362666781000},"page":"505-509","source":"Crossref","is-referenced-by-count":13,"title":["A comparison of intravenous immunoglobulin (2\u200ag\/kg totally) and single doses of anti-D immunoglobulin at 50\u200a\u03bcg\/kg, 75\u200a\u03bcg\/kg in newly diagnosed children with idiopathic thrombocytopenic purpura"],"prefix":"10.1097","volume":"24","author":[{"given":"Bulent","family":"Alioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirma","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Esra","family":"Tapci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugba","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Yazarli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yildiz","family":"Dallar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210203","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura.","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(01)07219-1","article-title":"Intercontinental Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study.","volume":"358","author":"Kuhne","year":"2001","journal-title":"Lancet"},{"key":"R3-8-20210203","first-page":"287","article-title":"Immune or idiopathic thrombocytopenic purpura (ITP) in childhood: what are the risks and who should be treated J P","volume":"143","author":"de Alarcon","year":"2003","journal-title":"ediatr"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00043426-200302000-00009","article-title":"American Society of Pediatric HematologyOncology, 2001. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric HematologyOncology, 2001.","volume":"25","author":"Vesely","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00043426-200308000-00017","article-title":"Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis.","volume":"25","author":"Butros","year":"2003","journal-title":"J Pediatr HematolOncol"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/S0022-3476(03)00535-3","article-title":"Intercontinental Childhood ITP Study Group; Intercontinental Childhood ITP Study Group. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.","volume":"143","author":"Kuhne","year":"2003","journal-title":"J Pediatr"},{"key":"R7-8-20210203","first-page":"480a","article-title":"Kirovski, Gregoire-Bottex M, Harris ME, Bussel JB. Intracranial hemorrhage in children with acute and chronic immune thrombocytopenic purpura.","volume":"100","year":"2002","journal-title":"Blood"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00043426-200310000-00011","article-title":"Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.","volume":"25","author":"Benesch","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s12098-008-0243-y","article-title":"Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.","volume":"75","author":"Shahgholi","year":"2008","journal-title":"Indian J Pediatr"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.2009.08057.x","article-title":"Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.","volume":"149","author":"Kane","year":"2010","journal-title":"Br J Haematol"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPH.0b013e31820e2aa5","article-title":"Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.","volume":"33","author":"Papagianni","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2141.2001.02627.x","article-title":"A dose of 75microgkgd of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50microgkgd in adults with immune thrombocytopenic purpura.","volume":"112","author":"Newman","year":"2001","journal-title":"Br J Haematol"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MPH.0b013e318142ac5f","article-title":"Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.","volume":"29","author":"Alioglu","year":"2007","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e32835e5337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:31:13Z","timestamp":1620959473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201307000-00008"}},"subtitle":["Ankara hospital experience"],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32835e5337","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}